David Hildick Smith - What’s new: clinical data published and presented since last year
New clinical data for left atrial appendage occlusion therapy, presented & published in 2016. Includes a critical review of the Stroke Prevention section in the 2016 ESC Atrial Fibrillation guidelines.
Matthew Price - What’s new: cost effectiveness and health economics
Why might LAA occlusion therapy be cost effective, despite a high procedural cost? This presentation is an overview of the health economics data available for left atrial appendage closure therapy.
David Meerkin - What’s new: new devices and new technologies
Review of new left atrial appendage occlusion devices that came to market (CE-mark) or underwent a major redesign in 2016.
Karen McCarthy - The left atrial appendage: from embryology to prevention of thromboembolism
Anatomy of left atrium specific focus on left atrial appendage. Important factors and anatomical landmarks for LAA occlusion.
Adel Aminian - From theory to practice: practical approaches for image fusion technology
Step-by-step device implantation of an Amplatzer Amulet left atrial appendage occluder implantation using Philips EchoNavigator imaging fusion technology.
Martin Swaans - Imaging Techniques: ICE, fusion imaging, and more
New tools and strategies for imaging. New tools: Philips EchoNavigator, future micro TEE probes etc.
Heyder Omran - Sizing, sizing, sizing. Does it need to be a discussion all the time?
Sizing in Left Atrial Appendage Occlusion therapy device implantation is still under debate. There are different devices and different methodologies discussed, while taking anatomical differences into account.
Jens Erik Nielsen Kudsk - Post implant therapies DAPT? ASA alone? Or NOAC?
Device thrombosis is still one of the most feared complications with left atrial appendage occlusion therapy. Post implant therapies are needed to avoid this complication. This presentation guides throughout the decision making process.